Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

Iterum Therapeutics plc (Nasdaq: ITRM) ('Iterum” or the 'Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...

Microplastics aren’t just everywhere — they might be turning your dinner into a breeding ground for supercharged pathogens.

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by ...

In 2023, the World Health Organization launched the Antimicrobial Resistance Diagnostic Initiative and called on researchers ...

Drawing on his research in understanding factors impacting infection tolerance, Brian P. Lazzaro discusses the importance of ...